Signaturefd, LLC Clearside Biomedical, Inc. Transaction History

Signaturefd, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$2.72 - $5.72 $775 - $1,630	-285 Reduced 0.52%	54,177 $149,000
Q3 2021 Oct 28, 2021	BUY	$4.83 - $7.2 $1,376 - $2,052	285 Added 0.53%	54,462 $327,000
Q4 2020 Feb 11, 2021	SELL	$1.32 - $2.74 $86,491 - $179,535	-65,524 Reduced 54.74%	54,177 $148,000
Q3 2020 Nov 03, 2020	SELL	$1.45 - $2.0 $2,392 - $3,300	-1,650 Reduced 1.36%	119,701 $184,000
Q2 2020 Jul 30, 2020	SELL	$1.55 - $2.41 $984 - $1,530	-635 Reduced 0.52%	121,351 $228,000
Q1 2020 Apr 23, 2020	BUY	$1.32 - $3.77 $84,031 - $239,998	63,660 Added 109.15%	121,986 $207,000
Q4 2019 Feb 05, 2020	SELL	$0.62 - $3.4 $77,909 - $427,244	-125,660 Reduced 68.3%	58,326 $169,000
Q4 2018 Feb 13, 2019	BUY	$1.0 - $6.12 $125,660 - $769,039	125,660 Added 215.44%	183,986 $197,000
Q3 2018 Nov 15, 2018	BUY	$6.03 - $11.24 $310,008 - $577,859	51,411 Added 743.47%	58,326 $359,000
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $61,612 - $100,544	6,915 New	6,915 $74,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.